Xiao-I Faces a Familiar Threat: Can a Chronically Money-Losing AI Firm Keep Its Nasdaq Seat?

Shares of Xiao-I Corporation (AIXI) slid 10.3% to $1.00 on August 10, pressured by investor anxiety over a fresh Nasdaq market-value deficiency notice disclosed August 6. The Shanghai-based enterprise AI company — which sells chatbot and voice-recognition tools to Chinese banks, insurers, and automakers — is once again bumping against the exchange's minimum thresholds, a pattern that has dogged the stock for two years running.

This Is the Third Time in Two Years Nasdaq Has Flagged the Stock

Xiao-I first received a bid-price deficiency warning in July 2024 , regaining compliance that September after its shares held above $1.00 for ten consecutive days . Then in December 2025 it was hit with two notices — one for the $1.00 bid price, the other for failing to keep the market value of publicly held shares above $15 million . Both were cleared by late May 2026 . Now, barely two months later, the market-value deficiency has resurfaced. A company that keeps tripping the same wire signals a business too small and too unprofitable to comfortably sustain a major-exchange listing.

The Financial Hole Is Deep — and Getting Deeper

In fiscal 2025, Xiao-I's revenue collapsed 82% to just $12.3 million, while net losses ballooned to $101.2 million . Trailing-twelve-month figures show a -37% operating margin and net losses of $26.5 million . The current ratio — a basic measure of whether a company can pay its near-term bills — sits at a perilous 0.12 . That means short-term debts dwarf available cash many times over.

Convertible Debt Is Keeping the Lights On, but Diluting Shareholders

In April 2026 the company issued convertible notes — loans that can be turned into stock — worth roughly $3.5 million in aggregate proceeds . A separate $2 million unsecured convertible note followed in June . Each conversion will create new shares, shrinking existing investors' ownership stakes. For a company whose market cap has cratered — Simply Wall St pegs it at roughly $2.2 million — even small dilutive financings are enormous relative to the company's size.

Delisting Risk Is the Real Bottom Line

If AIXI cannot regain compliance and Nasdaq does not grant additional relief, the company faces potential delisting . Losing its U.S. listing would cut off its primary channel for raising dollars and sharply reduce trading liquidity. At $1.00, the stock is right on the bid-price threshold — one bad day away from triggering yet another compliance clock.